Delivery Order SPE2DB20D3101-SPE2DB24FRKP3

Award Date 5/17/24
Potential Completion Date 5/20/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has a ceiling value of $12,676.02 and runs through January 22, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,112.14, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. This contract is not designated as a set-aside, indicating open...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product used in the treatment of diabetes. The contract has a ceiling value of $6,719.63 and a period of performance through January 22, 2024. The contract is a Firm Fixed Price arrangement and was not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,552.65 firm fixed-price contract is for the supply of JANUMET 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product used for diabetes management. The total ceiling value of the contract is $6,640.97, with a completion date of December 14, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $7,138.13 and a completion date of June 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,852.60, is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of May 20, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,716.20 and has an ultimate completion date of March 21, 2025. It is for the supply of JANUMET 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,044.44, is for the supply of JANUMET 50-1,000 MG TABLET 180S, a diabetes medication. The contract has a firm fixed-price pricing structure and a completion date of May 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,858.11, is for the provision of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. This contract award is not associated with any set-aside...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRKP3
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $4,713.50 and a period of performance ending on May 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 11:46 AM